美国NuGEN Technologies Inc
NuGEN公司成功革新了扩增和样品制备技术，使生命科学研究者能将那些极小的、易降解的和难以取代的标本发掘成为基因研究样本。
NuGEN公司的微量核酸制备技术为世界顶尖的医药公司、科研院所和尖端的生物技术公司带来了解决方案，以满足他们在临床研究、表达谱分析、生物标志物及标签的发现过程中遇到的艰难挑战。
NuGEN为各种尖端的基因分析平台提供了简捷、可靠、自动化的工作流程，包括新一代测序、微阵列分析和定量PCR。产品用于样品的制备，包括纯化RNA、DNA或者细胞裂解液，为特异的下游分析做准备。
NuGEN公司的产品主要分两部分：
Next-Generation Sequencing(NGS),Microarrays and qPCR。


NuGEN develops and commercializes rapid, high-sensitivity, and high-throughput amplification and labeling systems for genomic analysis.
Our innovations have captured the attention and imagination of life scientists studying the molecular basis of cellular responses, elucidating disease pathways, investigating novel expression biomarkers, discovering disease signatures, identifying and validating drug targets, and more.
Using our proprietary technologies as the foundation of products, NuGEN develops and commercializes solutions for high-sensitivity nucleic acid amplification and target preparation. With these solutions, life scientists can generate more meaningful answers, increase productivity, and achieve more significant discoveries in their quest to understand the molecular basis of disease, to discover novel biomarkers, and to identify and validate new drug targets.
NuGEN uniquely enables researchers to perform robust, high-fidelity expression analysis from limited and highly compromised clinical specimens. These solutions help researchers unlock discoveries in previously inaccessible samples such as formalin-fixed paraffin-embedded (FFPE), laser-captured, micro-dissected tissue (LCM), and others.
Founded in 2000, NuGEN Technologies, Inc. is privately held and headquartered in San Carlos, California near the heart of Silicon Valley. The company has commercialized numerous proprietary RNA amplification and labeling technologies and products for discovery and clinical research applications.